annual CFF:
$44.16M-$142.08M(-76.29%)Summary
- As of today (May 29, 2025), WGS annual cash flow from financing activities is $44.16 million, with the most recent change of -$142.08 million (-76.29%) on December 31, 2024.
- During the last 3 years, WGS annual CFF has fallen by -$449.57 million (-91.06%).
- WGS annual CFF is now -91.06% below its all-time high of $493.73 million, reached on December 31, 2021.
Performance
WGS Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$13.72M-$17.30M(-55.78%)Summary
- As of today (May 29, 2025), WGS quarterly cash flow from financing activities is $13.72 million, with the most recent change of -$17.30 million (-55.78%) on March 31, 2025.
- Over the past year, WGS quarterly CFF has increased by +$14.16 million (+3231.96%).
- WGS quarterly CFF is now -97.25% below its all-time high of $499.40 million, reached on September 1, 2021.
Performance
WGS quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$58.32M+$14.16M(+32.05%)Summary
- As of today (May 29, 2025), WGS TTM cash flow from financing activities is $58.32 million, with the most recent change of +$14.16 million (+32.05%) on March 31, 2025.
- Over the past year, WGS TTM CFF has increased by +$5.18 million (+9.74%).
- WGS TTM CFF is now -91.62% below its all-time high of $696.27 million, reached on June 1, 2022.
Performance
WGS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
WGS Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -76.3% | +3232.0% | +9.7% |
| 3 y3 years | -91.1% | +8673.8% | -88.2% |
| 5 y5 years | -70.2% | - | - |
WGS Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -91.1% | at low | -93.1% | +1605.8% | -91.6% | +32.0% |
| 5 y | 5-year | -91.1% | at low | -97.3% | +679.1% | -91.6% | +1355.0% |
| alltime | all time | -91.1% | at low | -97.3% | +679.1% | -91.6% | +1355.0% |
WGS Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $13.72M(-55.8%) | $58.32M(+32.1%) |
| Dec 2024 | $44.16M(-76.3%) | $31.02M(+122.1%) | $44.16M(-26.7%) |
| Sep 2024 | - | $13.97M(-3672.4%) | $60.24M(+32.8%) |
| Jun 2024 | - | -$391.00K(-10.7%) | $45.36M(-14.6%) |
| Mar 2024 | - | -$438.00K(-100.9%) | $53.14M(-71.5%) |
| Dec 2023 | $186.24M(-5.6%) | $47.10M(-5270.5%) | $186.24M(+33.8%) |
| Sep 2023 | - | -$911.00K(-112.3%) | $139.20M(-0.2%) |
| Jun 2023 | - | $7.39M(-94.4%) | $139.46M(-57.8%) |
| Mar 2023 | - | $132.66M(>+9900.0%) | $330.13M(+67.3%) |
| Dec 2022 | $197.31M | $65.00K(-110.0%) | $197.31M(+0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$647.00K(-100.3%) | $196.22M(-71.8%) |
| Jun 2022 | - | $198.06M(<-9900.0%) | $696.27M(+40.4%) |
| Mar 2022 | - | -$160.00K(-84.5%) | $495.85M(+0.4%) |
| Dec 2021 | $493.73M(+282.6%) | - | - |
| Dec 2021 | - | -$1.03M(-100.2%) | $493.73M(-0.2%) |
| Sep 2021 | - | $499.40M(<-9900.0%) | $494.76M(<-9900.0%) |
| Jun 2021 | - | -$2.37M(+4.0%) | -$4.65M(+104.0%) |
| Mar 2021 | - | -$2.28M | -$2.28M |
| Dec 2020 | $129.06M(-12.8%) | - | - |
| Dec 2019 | $148.01M | - | - |
FAQ
- What is GeneDx Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for GeneDx Holdings?
- What is GeneDx Holdings annual CFF year-on-year change?
- What is GeneDx Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for GeneDx Holdings?
- What is GeneDx Holdings quarterly CFF year-on-year change?
- What is GeneDx Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for GeneDx Holdings?
- What is GeneDx Holdings TTM CFF year-on-year change?
What is GeneDx Holdings annual cash flow from financing activities?
The current annual CFF of WGS is $44.16M
What is the all time high annual CFF for GeneDx Holdings?
GeneDx Holdings all-time high annual cash flow from financing activities is $493.73M
What is GeneDx Holdings annual CFF year-on-year change?
Over the past year, WGS annual cash flow from financing activities has changed by -$142.08M (-76.29%)
What is GeneDx Holdings quarterly cash flow from financing activities?
The current quarterly CFF of WGS is $13.72M
What is the all time high quarterly CFF for GeneDx Holdings?
GeneDx Holdings all-time high quarterly cash flow from financing activities is $499.40M
What is GeneDx Holdings quarterly CFF year-on-year change?
Over the past year, WGS quarterly cash flow from financing activities has changed by +$14.16M (+3231.96%)
What is GeneDx Holdings TTM cash flow from financing activities?
The current TTM CFF of WGS is $58.32M
What is the all time high TTM CFF for GeneDx Holdings?
GeneDx Holdings all-time high TTM cash flow from financing activities is $696.27M
What is GeneDx Holdings TTM CFF year-on-year change?
Over the past year, WGS TTM cash flow from financing activities has changed by +$5.18M (+9.74%)